Suppr超能文献

使用诊断准确性作为评估使用混合组织RNA参考样本的微阵列分析实验室熟练度的指标。

Use of diagnostic accuracy as a metric for evaluating laboratory proficiency with microarray assays using mixed-tissue RNA reference samples.

作者信息

Pine P S, Boedigheimer M, Rosenzweig B A, Turpaz Y, He Y D, Delenstarr G, Ganter B, Jarnagin K, Jones W D, Reid L H, Thompson K L

机构信息

Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, USA.

出版信息

Pharmacogenomics. 2008 Nov;9(11):1753-63. doi: 10.2217/14622416.9.11.1753.

Abstract

Effective use of microarray technology in clinical and regulatory settings is contingent on the adoption of standard methods for assessing performance. The MicroArray Quality Control project evaluated the repeatability and comparability of microarray data on the major commercial platforms and laid the groundwork for the application of microarray technology to regulatory assessments. However, methods for assessing performance that are commonly applied to diagnostic assays used in laboratory medicine remain to be developed for microarray assays. A reference system for microarray performance evaluation and process improvement was developed that includes reference samples, metrics and reference datasets. The reference material is composed of two mixes of four different rat tissue RNAs that allow defined target ratios to be assayed using a set of tissue-selective analytes that are distributed along the dynamic range of measurement. The diagnostic accuracy of detected changes in expression ratios, measured as the area under the curve from receiver operating characteristic plots, provides a single commutable value for comparing assay specificity and sensitivity. The utility of this system for assessing overall performance was evaluated for relevant applications like multi-laboratory proficiency testing programs and single-laboratory process drift monitoring. The diagnostic accuracy of detection of a 1.5-fold change in signal level was found to be a sensitive metric for comparing overall performance. This test approaches the technical limit for reliable discrimination of differences between two samples using this technology. We describe a reference system that provides a mechanism for internal and external assessment of laboratory proficiency with microarray technology and is translatable to performance assessments on other whole-genome expression arrays used for basic and clinical research.

摘要

在临床和监管环境中有效使用微阵列技术取决于采用评估性能的标准方法。微阵列质量控制项目评估了主要商业平台上微阵列数据的可重复性和可比性,并为将微阵列技术应用于监管评估奠定了基础。然而,用于评估医学实验室诊断检测的性能评估方法仍有待开发用于微阵列检测。开发了一种用于微阵列性能评估和过程改进的参考系统,该系统包括参考样本、指标和参考数据集。参考材料由四种不同大鼠组织RNA的两种混合物组成,这些混合物允许使用一组沿测量动态范围分布的组织选择性分析物来检测定义的目标比率。以接收器操作特征图的曲线下面积衡量的检测到的表达比率变化的诊断准确性提供了一个单一的可互换值,用于比较检测的特异性和灵敏度。该系统在多实验室能力验证计划和单实验室过程漂移监测等相关应用中评估了评估整体性能的效用。发现检测信号水平1.5倍变化的诊断准确性是比较整体性能的敏感指标。该测试接近使用该技术可靠区分两个样本之间差异的技术极限。我们描述了一种参考系统,该系统提供了一种通过微阵列技术对实验室能力进行内部和外部评估的机制,并且可以转化为对用于基础和临床研究的其他全基因组表达阵列的性能评估。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验